• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

早产趋势:城市机构的变化对 17α-羟孕酮己酸酯的公共卫生影响有何提示?

Trends in prematurity: what do changes at an urban institution suggest about the public health impact of 17-alpha hydroxyprogesterone caproate?

机构信息

Maternal and Child Health Research Program, Department of Obstetrics & Gynecology, Center for Research on Reproduction and Women's Health, University of Pennsylvania, Philadelphia, PA 19104, USA.

出版信息

Matern Child Health J. 2012 Apr;16(3):564-8. doi: 10.1007/s10995-011-0783-z.

DOI:10.1007/s10995-011-0783-z
PMID:21484515
Abstract

Despite the introduction of 17-alpha-hydroxyprogesterone caproate (17P), the national preterm birth (PTB) rate remains unchanged. Our objectives were to determine whether the overall rate of PTB has decreased and whether there has been a shift in the trends of prematurity at our institution since the initiation of 17P use. We performed a cross sectional study of the PTB rate and gestational age distribution at delivery (GA-del) at our institution over two, 2-year time periods: TP1 (pre 17P, 1 Jan 2004-31 Dec 2005) and TP2 (post 17P, 1 Jan 2008-31 Dec 2009). Statistical analyses included χ(2) tests for categorical data, t-tests for continuous data, and multivariable logistic regression to control for confounders. Overall (n = 15,421), there was no difference in the rate of PTB from TP1 to TP2 (16.65 vs 16.95%, p = 0.62). Among those with a history of prior PTB (n = 2,141), the mean preterm GA-del was 10 days later in TP2 than in TP1 (33.13 vs 31.64 weeks, p < 0.01) and significantly more preterm infants in TP2 delivered between 34-36 6/7 weeks than in TP1 (65.00 vs 45.63%, p < 0.01). The odds of a preterm infant delivering in the late preterm period was 2.3-fold higher in TP2 than TP1 (95% CI 1.49-3.54) after controlling for confounders. The significant shift in GA-del towards the late preterm period in TP2 may be due to the introduction of 17P use at our institution. Additional studies are needed to determine whether these trends persist on a nationwide level.

摘要

尽管已经引入了 17-α-羟孕酮己酸酯(17P),但全国性的早产(PTB)率仍保持不变。我们的目标是确定自使用 17P 以来,我们机构的 PTB 总体发生率是否降低,以及早产趋势是否发生变化。我们对我们机构在两个为期 2 年的时间内的 PTB 发生率和分娩时的孕龄分布(GA-del)进行了横断面研究:TP1(17P 前,2004 年 1 月 1 日至 2005 年 12 月 31 日)和 TP2(17P 后,2008 年 1 月 1 日至 2009 年 12 月 31 日)。统计分析包括卡方检验用于分类数据,t 检验用于连续数据,以及多变量逻辑回归来控制混杂因素。总体上(n=15421),从 TP1 到 TP2,PTB 的发生率没有差异(16.65%对 16.95%,p=0.62)。在有早产史的患者中(n=2141),TP2 的平均早产 GA-del 比 TP1 晚 10 天(33.13 对 31.64 周,p<0.01),并且在 TP2 中,更多的早产婴儿在 34-36 6/7 周之间分娩,而在 TP1 中,这一比例为 45.63%(65.00%对 45.63%,p<0.01)。在校正混杂因素后,TP2 中早产儿在晚期早产期间分娩的几率是 TP1 的 2.3 倍(95%CI 1.49-3.54)。TP2 中 GA-del 向晚期早产的显著转移可能是由于我们机构引入了 17P 的使用。需要进一步的研究来确定这些趋势是否在全国范围内持续存在。

相似文献

1
Trends in prematurity: what do changes at an urban institution suggest about the public health impact of 17-alpha hydroxyprogesterone caproate?早产趋势:城市机构的变化对 17α-羟孕酮己酸酯的公共卫生影响有何提示?
Matern Child Health J. 2012 Apr;16(3):564-8. doi: 10.1007/s10995-011-0783-z.
2
Gestational age at initiation of 17-alpha hydroxyprogesterone caproate and recurrent preterm birth.己酸17-α羟孕酮起始时的孕周与复发性早产
Am J Obstet Gynecol. 2017 Sep;217(3):371.e1-371.e7. doi: 10.1016/j.ajog.2017.05.022. Epub 2017 May 17.
3
17-alpha Hydroxyprogesterone caproate did not reduce the rate of recurrent preterm birth in a prospective cohort study.在一项前瞻性队列研究中,己酸17-α羟孕酮并未降低复发性早产的发生率。
Am J Obstet Gynecol. 2017 Jun;216(6):600.e1-600.e9. doi: 10.1016/j.ajog.2017.02.025. Epub 2017 Feb 20.
4
17-alpha-hydroxyprogesterone caproate for the prevention of preterm birth in women with prior preterm birth and a short cervical length.17α-羟孕酮己酸酯预防有早产史且宫颈较短孕妇的早产。
Am J Obstet Gynecol. 2010 Apr;202(4):351.e1-6. doi: 10.1016/j.ajog.2010.02.019.
5
The association among cytochrome P450 3A, progesterone receptor polymorphisms, plasma 17-alpha hydroxyprogesterone caproate concentrations, and spontaneous preterm birth.细胞色素P450 3A、孕激素受体多态性、血浆己酸17-α羟孕酮浓度与自发性早产之间的关联。
Am J Obstet Gynecol. 2017 Sep;217(3):369.e1-369.e9. doi: 10.1016/j.ajog.2017.05.019. Epub 2017 May 15.
6
Predictors of response to 17-alpha hydroxyprogesterone caproate for prevention of recurrent spontaneous preterm birth.己酸17-α羟孕酮预防复发性自发性早产疗效的预测因素
Am J Obstet Gynecol. 2016 Mar;214(3):376.e1-8. doi: 10.1016/j.ajog.2015.12.010. Epub 2015 Dec 12.
7
A randomised trial to compare 200 mg micronised progesterone effervescent vaginal tablet daily with 250 mg intramuscular 17 alpha hydroxy progesterone caproate weekly for prevention of recurrent preterm birth.一项随机试验,比较每日200毫克微粉化孕酮泡腾阴道片与每周250毫克肌肉注射己酸17α-羟孕酮预防复发性早产的效果。
J Obstet Gynaecol. 2018 Aug;38(6):800-806. doi: 10.1080/01443615.2018.1425380. Epub 2018 Mar 20.
8
The effect of 17α-hydroxyprogesterone caproate on preterm birth in women with an ultrasound-indicated cerclage.超声提示宫颈环扎术孕妇应用 17α-羟孕酮治疗早产的效果。
Am J Perinatol. 2011 May;28(5):389-94. doi: 10.1055/s-0031-1272967. Epub 2011 Mar 4.
9
17-OHPC to Prevent Recurrent Preterm Birth in Singleton Gestations (PROLONG Study): A Multicenter, International, Randomized Double-Blind Trial.17-OHPC 预防单胎妊娠早产复发(PROLONG 研究):一项多中心、国际、随机、双盲试验。
Am J Perinatol. 2020 Jan;37(2):127-136. doi: 10.1055/s-0039-3400227. Epub 2019 Oct 25.
10
Prevention of preterm birth in triplets using 17 alpha-hydroxyprogesterone caproate: a randomized controlled trial.使用己酸17α-羟孕酮预防三胞胎早产:一项随机对照试验。
Obstet Gynecol. 2009 Feb;113(2 Pt 1):285-92. doi: 10.1097/AOG.0b013e318193c677.

引用本文的文献

1
Inequality and Innovation: Barriers and Facilitators to 17P Administration to Prevent Preterm Birth among Medicaid Participants.不平等与创新:医疗补助计划参与者中使用17P预防早产的管理障碍与促进因素
Matern Child Health J. 2018 Nov;22(11):1607-1616. doi: 10.1007/s10995-018-2556-4.
2
Demystifying animal models of adverse pregnancy outcomes: touching bench and bedside.揭开不良妊娠结局动物模型的神秘面纱:从 bench 到 bedside。
Am J Reprod Immunol. 2013 Jun;69(6):567-84. doi: 10.1111/aji.12102. Epub 2013 Feb 28.
3
Progesterone supplementation and the prevention of preterm birth.

本文引用的文献

1
Adverse neonatal outcomes: examining the risks between preterm, late preterm, and term infants.不良新生儿结局:探讨早产、晚期早产和足月儿之间的风险。
Am J Obstet Gynecol. 2008 Oct;199(4):367.e1-8. doi: 10.1016/j.ajog.2008.08.002.
2
Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate.己酸17α-羟孕酮预防复发性早产
N Engl J Med. 2003 Jun 12;348(24):2379-85. doi: 10.1056/NEJMoa035140.
3
Classification and heterogeneity of preterm birth.早产的分类与异质性
补充孕酮与预防早产
Rev Obstet Gynecol. 2011 Summer;4(2):60-72.
BJOG. 2003 Apr;110 Suppl 20:30-3. doi: 10.1016/s1470-0328(03)00021-1.
4
ACOG Practice Bulletin. Assessment of risk factors for preterm birth. Clinical management guidelines for obstetrician-gynecologists. Number 31, October 2001. (Replaces Technical Bulletin number 206, June 1995; Committee Opinion number 172, May 1996; Committee Opinion number 187, September 1997; Committee Opinion number 198, February 1998; and Committee Opinion number 251, January 2001).美国妇产科医师学会实践公告。早产风险因素评估。妇产科临床管理指南。第31号,2001年10月。(取代1995年6月的技术公告第206号;1996年5月的委员会意见第172号;1997年9月的委员会意见第187号;1998年2月的委员会意见第198号;以及2001年1月的委员会意见第251号)
Obstet Gynecol. 2001 Oct;98(4):709-16.
5
Progestogen administration in pregnancy may prevent preterm delivery.孕期使用孕激素可能预防早产。
Br J Obstet Gynaecol. 1990 Feb;97(2):149-54. doi: 10.1111/j.1471-0528.1990.tb01740.x.